News

05.02.2017

Availability issues for approved drugs. Case study: Nabiximols

By Harriet Doig MS Ireland includes the availability and reimbursement of MS drugs among its priorities as a patient organisation….

EMSP 2017 Conference: Registrations open

26.01.2017

We are inviting members, partners and supporters to register for our 2017 Spring Conference. The two-day event is held in Athens,…

Let’s stay in touch!

26.01.2017

We are inviting you – our valuable member societies – to provide us with your up to date contact details…

26.01.2017

Highlights of MS research in 2016

The MS International Federation (MSIF) and the UK MS Society have captured the highlights of 2016 MS research in two…

Let’s stay in touch!

26.01.2017

We are inviting you – our valuable member societies – to provide us with your up to date contact details…

Highlights of MS research in 2016

26.01.2017

The MS International Federation (MSIF) and the UK MS Society have captured the highlights of 2016 MS research in two…

26.01.2017

EMSP 2017 Conference: Registrations open

We are inviting members, partners and supporters to register for our 2017 Spring Conference. The two-day event is held in Athens,…

European Commission publishes guide on biosimilar medicines

25.01.2017

The European Commission has published a Q&A guide on biosimilar medicines for patients. The document is available in seven languages (English, French,…

European Commission publishes guide on biosimilar medicines

25.01.2017

The European Commission has published a Q&A guide on biosimilar medicines for patients. The document is available in seven languages (English, French,…

1 33 34 35 36 37 67